GOLDMAN SACHS GROUP INC - HOOKIPA PHARMA INC ownership

HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 73 filers reported holding HOOKIPA PHARMA INC in Q2 2021. The put-call ratio across all filers is 8.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of HOOKIPA PHARMA INC
ValueSharesWeighting
Q3 2022$24,000
-67.1%
18,093
-59.1%
0.00%
Q2 2022$73,000
-63.3%
44,253
-49.3%
0.00%
Q1 2022$199,000
+114.0%
87,217
+117.8%
0.00%
Q4 2021$93,000
+13.4%
40,049
+186.9%
0.00%
Q3 2021$82,000
-74.1%
13,958
-59.6%
0.00%
Q2 2021$316,000
-86.5%
34,526
-80.2%
0.00%
-100.0%
Q1 2021$2,340,000
+1009.0%
173,978
+813.3%
0.00%
Q4 2020$211,000
-16.9%
19,049
-49.5%
0.00%
Q2 2019$254,00037,7050.00%
Other shareholders
HOOKIPA PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 1,842,902$17,452,0000.32%
Samsara BioCapital, LLC 116,602$1,104,0000.31%
Artal Group S.A. 599,616$5,678,0000.14%
HHLR ADVISORS, LTD. 943,254$8,933,0000.07%
DAFNA Capital Management LLC 22,061$209,0000.07%
Baker Brothers Advisors 700,481$6,634,0000.03%
ZACKS INVESTMENT MANAGEMENT 72,064$682,0000.01%
HOWLAND CAPITAL MANAGEMENT LLC 14,728$139,0000.01%
ETF MANAGERS GROUP, LLC 14,374$139,0000.00%
Squarepoint Ops LLC 12,699$120,0000.00%
View complete list of HOOKIPA PHARMA INC shareholders